Kynamro

Isis: Big Pharma's Little Friend

Isis: Big Pharma's Little Friend

Motley Fool

EMA rejects Genzyme re-examination request for Kynamro

EMA rejects Genzyme re-examination request for Kynamro

Yahoo/Fly on the Wall

Will Isis Right Pfizer's Wrong?

Will Isis Right Pfizer's Wrong?

Motley Fool

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Seeking Alpha

FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Comment Now Follow Comments

FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

Forbes

4 Can't-Miss Health-Care Events This Week

4 Can't-Miss Health-Care Events This Week

Motley Fool

Better Than Lipitor! Higher Sales?

Better Than Lipitor! Higher Sales?

Motley Fool

3 Things to Watch at Isis Pharmaceuticals

3 Things to Watch at Isis Pharmaceuticals

Motley Fool

Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO

Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO

Yahoo/Fly on the Wall

Isis Trading Halts as FDA Reviews Key Drug's Risks

Isis Trading Halts as FDA Reviews Key Drug's Risks

PharmPro